Td Asset Management Inc Novartis Ag Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

A detailed history of Td Asset Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Td Asset Management Inc holds 16,107 shares of NVS stock, worth $1.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,107
Previous 16,425 1.94%
Holding current value
$1.59 Million
Previous $1.75 Million 5.95%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$106.13 - $120.89 $33,749 - $38,443
-318 Reduced 1.94%
16,107 $1.85 Million
Q2 2024

Aug 02, 2024
SELL
$92.57 - $107.37 $3.29 Million - $3.81 Million
-35,531 Reduced 68.39%
16,425 $1.75 Million
Q1 2024

May 08, 2024
SELL
$95.27 - $108.47 $299,147 - $340,595
-3,140 Reduced 5.7%
51,956 $5.03 Million
Q4 2023

Feb 12, 2024
BUY
$92.27 - $101.54 $3.86 Million - $4.25 Million
41,815 Added 314.85%
55,096 $5.56 Million
Q3 2023

Oct 27, 2023
BUY
$94.73 - $105.13 $6,346 - $7,043
67 Added 0.51%
13,281 $1.35 Million
Q2 2023

Aug 09, 2023
SELL
$92.52 - $104.91 $51,441 - $58,329
-556 Reduced 4.04%
13,214 $1.33 Million
Q1 2023

May 10, 2023
SELL
$80.03 - $92.81 $57,541 - $66,730
-719 Reduced 4.96%
13,770 $1.27 Million
Q4 2022

Feb 06, 2023
SELL
$75.55 - $92.52 $8,914 - $10,917
-118 Reduced 0.81%
14,489 $1.31 Million
Q3 2022

Nov 07, 2022
BUY
$74.61 - $87.26 $110,273 - $128,970
1,478 Added 11.26%
14,607 $1.12 Million
Q2 2022

Aug 04, 2022
BUY
$80.52 - $93.75 $1,932 - $2,250
24 Added 0.18%
13,129 $1.11 Million
Q1 2022

May 10, 2022
SELL
$80.11 - $90.62 $22,430 - $25,373
-280 Reduced 2.09%
13,105 $1.15 Million
Q4 2021

Feb 10, 2022
SELL
$79.7 - $88.13 $5,260 - $5,816
-66 Reduced 0.49%
13,385 $1.17 Million
Q3 2021

Nov 09, 2021
SELL
$81.78 - $95.14 $2.66 Million - $3.09 Million
-32,478 Reduced 70.71%
13,451 $1.1 Million
Q2 2021

Aug 11, 2021
BUY
$85.24 - $94.15 $39,977 - $44,156
469 Added 1.03%
45,929 $4.24 Million
Q1 2021

May 14, 2021
BUY
$83.5 - $98.47 $238,977 - $281,821
2,862 Added 6.72%
45,460 $3.89 Million
Q4 2020

Feb 16, 2021
SELL
$78.07 - $94.43 $1.06 Million - $1.28 Million
-13,575 Reduced 24.17%
42,598 $4.02 Million
Q3 2020

Nov 10, 2020
SELL
$82.14 - $91.0 $7.95 Million - $8.81 Million
-96,799 Reduced 63.28%
56,173 $4.89 Million
Q2 2020

Aug 13, 2020
SELL
$80.93 - $91.1 $1.45 Million - $1.63 Million
-17,915 Reduced 10.48%
152,972 $13.4 Million
Q1 2020

May 15, 2020
BUY
$70.67 - $99.01 $705,781 - $988,812
9,987 Added 6.21%
170,887 $14.1 Million
Q4 2019

Feb 11, 2020
SELL
$84.35 - $95.37 $85,783 - $96,991
-1,017 Reduced 0.63%
160,900 $15.2 Million
Q3 2019

Nov 07, 2019
SELL
$85.54 - $94.26 $169,967 - $187,294
-1,987 Reduced 1.21%
161,917 $14.1 Million
Q2 2019

Aug 01, 2019
SELL
$75.4 - $92.8 $334,776 - $412,032
-4,440 Reduced 2.64%
163,904 $15 Million
Q1 2019

May 08, 2019
SELL
$75.32 - $86.15 $2.28 Million - $2.61 Million
-30,247 Reduced 15.23%
168,344 $16.2 Million
Q4 2018

Feb 01, 2019
SELL
$73.66 - $82.02 $460,080 - $512,296
-6,246 Reduced 3.05%
198,591 $17 Million
Q3 2018

Nov 01, 2018
BUY
$66.94 - $77.43 $1.17 Million - $1.35 Million
17,498 Added 9.34%
204,837 $17.6 Million
Q2 2018

Jul 31, 2018
BUY
$64.91 - $73.36 $1.33 Million - $1.5 Million
20,499 Added 12.29%
187,339 $14.2 Million
Q1 2018

May 11, 2018
BUY
$70.39 - $84.15 $700,802 - $837,797
9,956 Added 6.35%
166,840 $13.5 Million
Q4 2017

Feb 02, 2018
BUY
$72.33 - $77.64 $1.24 Million - $1.33 Million
17,172 Added 12.29%
156,884 $13.2 Million
Q3 2017

Nov 09, 2017
BUY
$74.14 - $77.27 $10.4 Million - $10.8 Million
139,712
139,712 $12 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email